A Role for the p38 Mitogen-activated Protein Kinase Pathway in Myocardial Cell Growth, Sarcomeric Organization, and Cardiac-specific Gene Expression
Open Access
- 6 October 1997
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 139 (1) , 115-127
- https://doi.org/10.1083/jcb.139.1.115
Abstract
Three hallmark features of the cardiac hypertrophic growth program are increases in cell size, sarcomeric organization, and the induction of certain cardiac-specific genes. All three features of hypertrophy are induced in cultured myocardial cells by α1- adrenergic receptor agonists, such as phenylephrine (PE) and other growth factors that activate mitogen- activated protein kinases (MAPKs). In this study the MAPK family members extracellular signal–regulated kinase (ERK), c-jun NH2-terminal kinase (JNK), and p38 were activated by transfecting cultured cardiac myocytes with constructs encoding the appropriate kinases possessing gain-of-function mutations. Transfected cells were then analyzed for changes in cell size, sarcomeric organization, and induction of the genes for the A- and B-type natriuretic peptides (NPs), as well as the α-skeletal actin (α-SkA) gene. While activation of JNK and/or ERK with MEKK1COOH or Raf-1 BXB, respectively, augmented cell size and effected relatively modest increases in NP and α-SkA promoter activities, neither upstream kinase conferred sarcomeric organization. However, transfection with MKK6 (Glu), which specifically activated p38, augmented cell size, induced NP and α-Ska promoter activities by up to 130-fold, and elicited sarcomeric organization in a manner similar to PE. Moreover, all three growth features induced by MKK6 (Glu) or PE were blocked with the p38-specific inhibitor, SB 203580. These results demonstrate novel and potentially central roles for MKK6 and p38 in the regulation of myocardial cell hypertrophy.Keywords
This publication has 98 references indexed in Scilit:
- Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammationNature, 1997
- Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat heartsFEBS Letters, 1996
- Dissociation of p44 and p42 Mitogen-activated Protein Kinase Activation from Receptor-induced Hypertrophy in Neonatal Rat Ventricular MyocytesPublished by Elsevier ,1996
- Tissue-Specific Expression of the Human Brain Natriuretic Peptide Gene in Cardiac MyocytesHypertension, 1996
- Hypertrophic Agonists Stimulate the Activities of the Protein Kinases c-Raf and A-Raf in Cultured Ventricular MyocytesJournal of Biological Chemistry, 1995
- The Mitogen-activated Protein Kinase Kinase MEK1 Stimulates a Pattern of Gene Expression Typical of the Hypertrophic Phenotype in Rat Ventricular CardiomyocytesPublished by Elsevier ,1995
- Ras Activity Is Required for Phenylephrine-Induced Activation of Mitogen-Activated Protein Kinase in Cardiac Muscle CellsBiochemical and Biophysical Research Communications, 1994
- Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy.The Journal of cell biology, 1994
- The Tyrosine Kinase Inhibitor, Genistein, Prevents α-Adrenergic-Induced Cardiac Muscle Cell Hypertrophy by Inhibiting Activation of the Ras-MAP Kinase Signaling PathwayBiochemical and Biophysical Research Communications, 1994
- Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein levelInflammation Research, 1993